In this episode our host Dr Sarah Drummond speaks with Professor Catherine Smith and Dr Andrew Pink about eczema therapeutics: • The use of JAK inhibitors licensed for use in managing eczema including their mechanism of action, monitoring requirements and potential side effects. • Newer agents currently under investigation. • The BEACON trial Recorded: 19 March 2024 For more information, visit: www.stjohnsdermacademy.com/podcasts Disclaimer: The information on our ...
All content for St John's DermAcademy Podcast is the property of St John's DermAcademy and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode our host Dr Sarah Drummond speaks with Professor Catherine Smith and Dr Andrew Pink about eczema therapeutics: • The use of JAK inhibitors licensed for use in managing eczema including their mechanism of action, monitoring requirements and potential side effects. • Newer agents currently under investigation. • The BEACON trial Recorded: 19 March 2024 For more information, visit: www.stjohnsdermacademy.com/podcasts Disclaimer: The information on our ...
Episode 15: Part 2: Immunobullous disorders - Pemphigus vulgaris
St John's DermAcademy Podcast
21 minutes
1 year ago
Episode 15: Part 2: Immunobullous disorders - Pemphigus vulgaris
In this episode our host Dr Sarah Drummond speaks with Dr Thomas Tull about pemphigus vulgaris: • The clinical features of pemphigus vulgaris and other variants of pemphigus. • The step-wise management of pemphigus vulgaris including an approach to managing severe disease and the use of rituximab and intravenous immunoglobulin . Resources and further reading: • British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris, 2017 (https://on...
St John's DermAcademy Podcast
In this episode our host Dr Sarah Drummond speaks with Professor Catherine Smith and Dr Andrew Pink about eczema therapeutics: • The use of JAK inhibitors licensed for use in managing eczema including their mechanism of action, monitoring requirements and potential side effects. • Newer agents currently under investigation. • The BEACON trial Recorded: 19 March 2024 For more information, visit: www.stjohnsdermacademy.com/podcasts Disclaimer: The information on our ...
